Related Experiment Video
Updated: Oct 12, 2025

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Longitudinal White Matter Damage Evolution in Parkinson's Disease
Pietro Giuseppe Scamarcia1,2, Federica Agosta1,2,3, Edoardo Gioele Spinelli1,2,3
1Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
White matter hyperintensities (WMHs) are linked to cognitive decline in Parkinson's disease (PD). Cerebral white matter microstructural damage does not significantly impact PD progression, but WMHs can predict cognitive impairment development.
Area of Science:
- Neuroimaging
- Neurology
- Gerontology
Background:
- White matter hyperintensities (WMHs) are implicated in cognitive decline during normal aging.
- The specific role of WMHs and white matter (WM) microstructural integrity in Parkinson's disease (PD) progression remains debated.
Purpose of the Study:
- To examine the long-term changes in cerebral white matter (WM) structure.
- To investigate the relationship between WM alterations and clinical progression in PD patients.
Main Methods:
- 154 PD patients and 60 controls underwent annual MRI scans and clinical/cognitive assessments for up to 4 years.
- Tract-based spatial statistics analyzed diffusion tensor (DT) MRI metrics in WM and normal-appearing white matter (NAWM).
- Linear mixed-effects models and regression analyses assessed longitudinal changes and risk factors for disease progression.
Main Results:
- PD patients exhibited baseline alterations in DT MRI measures compared to controls.
- WMH volume increased over time and correlated with cognitive impairments (global, executive, language).
- Baseline WMH volume moderately predicted progression to mild cognitive impairment.
Conclusions:
- WMHs are associated with cognitive decline in PD patients.
- Cerebral white matter microstructural damage has minimal impact on clinical PD progression.
- MRI-assessed WMHs serve as a valuable tool for monitoring cognitive impairment development in PD.
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

